Literature DB >> 18835844

Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity.

Domenico Rendina1, Giuseppe Mossetti, Gianpaolo De Filippo, Domenico Benvenuto, Carmen Liliana Vivona, Alessia Imbroinise, Giorgia Zampa, Salvatore Ricchio, Pasquale Strazzullo.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) and nephrolithiasis (NL) are quite common disorders. While some of the components of MetS have been proposed as precursors of NL in population studies, no data are available about the possible association between NL and MetS as such. The primary objective of the study was to evaluate the relationship between MetS and NL. The secondary outcome was to examine the relationship between MetS single constitutive elements and NL considering the strict correlation occurring among these factors.
METHODS: We studied 2132 Caucasian inpatients of the 'Spinelli' Hospital in southern Italy (males/females = 0.95; mean age 63.8 +/- 15.8 years; body mass index 26.1 +/- 3.9 kg/m(2)). The MetS diagnosis was performed according to the Heart Association/National Heart, Lung, and Blood Institute criteria. The presence of NL was assessed by ultrasound examination of the kidneys and upper urinary tract.
RESULTS: Seven hundred twenty-five subjects (34.0%) had a positive diagnosis of MetS. Two hundred twenty subjects (10.3%) had echographic evidence of NL, while 199 subjects reported a past history of NL (9.3%). The presence of MetS, as well as the male sex, and the occurrence of a previous episode of NL (in male subjects only) were each independently related to echographic evidence of NL. Among the individual components of MetS, high blood pressure and abdominal obesity (in female individuals only) were also independently related to echographic evidence of NL.
CONCLUSIONS: MetS is significantly associated with echographic evidence of NL. A gender-related difference in the clinical expression of NL was also observed.

Entities:  

Mesh:

Year:  2008        PMID: 18835844     DOI: 10.1093/ndt/gfn548

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  45 in total

1.  Obesity and Its Impact on Kidney Stone Formation.

Authors:  William Poore; Carter J Boyd; Nikhi P Singh; Kyle Wood; Barbara Gower; Dean G Assimos
Journal:  Rev Urol       Date:  2020

2.  Metabolic syndrome contributes to renal injury mediated by hyperoxaluria in a murine model of nephrolithiasis.

Authors:  Javier Sáenz-Medina; E Jorge; C Corbacho; M Santos; A Sánchez; P Soblechero; E Virumbrales; E Ramil; M J Coronado; I Castillón; D Prieto; J Carballido
Journal:  Urolithiasis       Date:  2017-04-12       Impact factor: 3.436

Review 3.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

4.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 5.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

6.  Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS.

Authors:  Mathew D Sorensen; Arnold J Kahn; Alex P Reiner; Timothy Y Tseng; James M Shikany; Robert B Wallace; Thomas Chi; Jean Wactawski-Wende; Rebecca D Jackson; Mary Jo O'Sullivan; Natalia Sadetsky; Marshall L Stoller
Journal:  J Urol       Date:  2012-03-14       Impact factor: 7.450

7.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

8.  Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension.

Authors:  Domenico Rendina; Renato Ippolito; Gianpaolo De Filippo; Riccardo Muscariello; Daniela De Palma; Silvana De Bonis; Michele Schiano di Cola; Domenico Benvenuto; Maurizio Galderisi; Pasquale Strazzullo; Ferruccio Galletti
Journal:  Intern Emerg Med       Date:  2016-08-26       Impact factor: 3.397

9.  Association of urolithiasis with systemic conditions among pediatric patients at children's hospitals.

Authors:  Paul J Kokorowski; Jonathan C Routh; Katherine C Hubert; Dionne A Graham; Caleb P Nelson
Journal:  J Urol       Date:  2012-08-18       Impact factor: 7.450

Review 10.  Nephrolithiasis and hypertension: possible links and clinical implications.

Authors:  Adamasco Cupisti; Claudia D'Alessandro; Sara Samoni; Mario Meola; Maria Francesca Egidi
Journal:  J Nephrol       Date:  2014-02-28       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.